BWA
PROK icon

Basecamp Wealth Advisors’s ProKidney PROK Stock Holding History

Basecamp Wealth Advisors’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2K Hold
586
– – ﹤0.01% 1477
2026
Q1 		$1.05K Sell
586
-134
-19% -$284 ﹤0.01% 1549
2025
Q4 		$1.61K Buy
+720
New +$1.89K ﹤0.01% 1400

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Basecamp Wealth Advisors's PROK Position: Q2 2026 in Review

Basecamp Wealth Advisors held its ProKidney (PROK) position steady in Q2 2026 at 586 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Basecamp Wealth Advisors first reported a position in PROK in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.61K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Basecamp Wealth Advisors held 586 shares of ProKidney worth $1.2K as of Q2 2026.
  • Basecamp Wealth Advisors left its ProKidney share count unchanged in Q2 2026.
  • ProKidney made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1477 holding.
  • Basecamp Wealth Advisors first reported a position in ProKidney in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's ProKidney position peaked at $1.61K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.